Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence?

Journal of Clinical Investigation

Volumn 113, Issue 1, 2004, Pages 4-7

  Pelicci, Pier Giuseppe ^a,b  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; PROTEIN P16; PROTEIN P53; TELOMERASE;

APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL ACTIVATION; CELL AGING; CELL DIVISION; CELL IMMORTALIZATION; DEPLETION; DNA DAMAGE; HOMEOSTASIS; HUMAN; LIFESPAN; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STRESS; TELOMERE; AGING; BIOLOGICAL MODEL; GENETICS; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

AGING; CELL AGING; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; STEM CELLS; TELOMERE;

EID: 1542781658     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420750     Document Type: Review

References (36)

1. Kim, N.W., et al. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:2011-2015.
2. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A., and Reddel, R.R. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271-1274.
3. Bodnar, A.G., et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:349-352.
4. Vaziri, H., and Benchimol, S. 1998. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8:279-282.
5. Hahn, W.C., et al. 1999. Creation of human tumor cells with defined genetic elements. Nature. 400:464-468.
6. Yui, J., Chiu, C.P., and Lansdorp, P.M. 1998. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood. 91:3255-3262.
7. Allsopp, R.C., and Weissman, I.L. 2002. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene. 21:3270-3273.
8. Rudolph, K.L., et al. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 96:701-712.
9. Hande, M.P., Samper, E., Lansdorp, P., and Blasco, M.A. 1999. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144:589-601.
10. Niida, H., et al. 1998. Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19:203-206.
11. Ben-Porath, I., and Weinberg, R.A. 2004. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113:8-13. doi:10.1172/JC1200420663.
12. Sharpless, N.E., and DePinho, R.A. 2004. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. In press.
13. Park, I.-K., Morrison, S.J., and Clarke, M.F. 2004. Bmi-I, stem cells, and senescence regulation. J. Clin. Invest. In press.
14. Kahlem, P., Dötken, B., and Schmitt, C.A. 2004. Cellular senescence in cancer treatment: friend or foe? J. Clin. Invest. In press.
15. Mathon, N.F., Malcolm, D.S., Harrisingh, M.C., Cheng, L., and Lloyd, A.C. 2001. Lack of replicative senescence in normal rodent glia. Science. 291:872-875.
16. Tang, D.G., Tokumoto, Y.M., Apperly, J.A., Lloyd, A.C. and Raff, M.C. 2001. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science. 291:868-871.
17. Ramirez, R.D., et al. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15:398-403.
18. Parrinello, S., et al. 2003. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5:741-747.
19. Chin, L., et al. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:527-538.
20. Arrandi, S.E., et al. 2002. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:641-645.
21. Buerger, H., et al. 1999. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J. Pathol. 187:396-402.
22. Gonzalez-Suarez, E., et al. 2001. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20:2619-2630.
23. Gonzalez-Suarez, E., Samper, E., Flores, J.M., and Blasco, M.A. 2000. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26:114-117.
24. Masutomi, K., et al. 2003. Telomerase maintains telomere structure in normal human cells. Cell. 114:241-253.
25. Passegue, E., Jamieson, C.H., Ailles, L.E., and Weissman, I.L. 2003. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl. Acad. Sci. U. S. A. 100(Suppl 1):11842-11849.
26. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:3983-3988.
27. Park, I.K., et al. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:302-305.
28. Molofsky, A.V., et al. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 425:962-967.
29. Schmitt, C.A., et al. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 109:335-346.
30. te Poele, R.H., Okorokov, A.L., Jardine, L., Cummings, J., and Joel, S.P. 2002. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62:1876-1883.
31. Tyner, S.D., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:45-53.
32. Garcia-Cao, I., et al. 2002. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21:6225-6235.
33. Davenport, R.J. 2002. Tumor-free, but not in the clear. Sci. Aging Knowl. Environ. 40:nw139.
34. Wong, K.K., et al. 2003. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature. 421:643-648
35. Migliaccio, E., et al. 1999. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 402:309-313.
36. Trinei, M., et al. 2002. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene. 21:3872-3878.